Probucol treatment attenuates the aortic atherosclerosis in Watanabe heritable hyperlipidemic rabbits

被引:24
作者
Oshima, R
Ikeda, T
Watanabe, K
Itakura, H
Sugiyama, N
机构
[1] Daiichi Pharmaceut Co Ltd, Exploratory Res Labs 2, Edogawa Ku, Tokyo 134, Japan
[2] Natl Inst Hlth & Nutr, Div Clin Nutr, Shinjuku Ku, Tokyo 162, Japan
关键词
probucol; Watanabe heritable hyperlipidemic rabbits; atherosclerosis; regression;
D O I
10.1016/S0021-9150(97)00243-8
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
We examined the effect of probucol on the aortic atherosclerosis already developed in Watanabe heritable hyperlipidemic (WHHL) rabbits at the initiation of treatment. In WHHL rabbits treated with probucol for 5 months from 8 months old, the lesion area in the aorta was significantly (P<0.05) reduced when compared with that in untreated animals as well as animals at age 8 months. In contrast, plasma cholesterol levels in the probucol-treated group and untreated group during the experiment were not significantly different. LDL prepared from rabbits receiving probucol for 5 months showed resistance to oxidation by copper ions. Plasma CETP activity was significantly (P<0.05) increased by probucol treatment. An immunohistochemical study showed that macrophages were abundant in the atherosclerotic lesions of untreated rabbits whereas smooth muscle cells were predominant in lesions of probucol-treated rabbits. These results suggest that the atherosclerotic lesion in WHHL rabbits can regress when treated by probucol and that the attenuation of atherosclerosis in this animal involves effects of probucol other than a decrease in plasma cholesterol, for example anti-oxidant activity. (C) 1998 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:13 / 22
页数:10
相关论文
共 31 条
[1]
ATMEH RF, 1983, J LIPID RES, V24, P588
[2]
CELLULAR PATHOLOGY OF PROGRESSIVE ATHEROSCLEROSIS IN THE WHHL RABBIT - AN ANIMAL-MODEL OF FAMILIAL HYPERCHOLESTEROLEMIA [J].
BUJA, LM ;
KITA, T ;
GOLDSTEIN, JL ;
WATANABE, Y ;
BROWN, MS .
ARTERIOSCLEROSIS, 1983, 3 (01) :87-101
[4]
THE EFFECTS OF PROBUCOL ON THE PROGRESSION OF ATHEROSCLEROSIS IN MATURE WATANABE HERITABLE HYPERLIPEMIC RABBITS [J].
DAUGHERTY, A ;
ZWEIFEL, BS ;
SCHONFELD, G .
BRITISH JOURNAL OF PHARMACOLOGY, 1991, 103 (01) :1013-1018
[5]
CONTINUOUS MONITORING OF INVITRO OXIDATION OF HUMAN LOW-DENSITY LIPOPROTEIN [J].
ESTERBAUER, H ;
STRIEGL, G ;
PUHL, H ;
ROTHENEDER, M .
FREE RADICAL RESEARCH COMMUNICATIONS, 1989, 6 (01) :67-75
[6]
ANTIATHEROSCLEROTIC EFFECT OF PROBUCOL IN WHHL RABBITS - ARE THERE PLASMA PARAMETERS TO EVALUATE THIS EFFECT [J].
FINCKH, B ;
NIENDORF, A ;
RATH, M ;
BEISIEGEL, U .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 40 :S77-S80
[7]
PROBUCOL INCREASES CHOLESTERYL ESTER TRANSFER PROTEIN-ACTIVITY IN HYPERCHOLESTEROLEMIC PATIENTS [J].
FRANCESCHINI, G ;
CHIESA, G ;
SIRTORI, CR .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1991, 21 (04) :384-388
[8]
A COMPARISON OF THE ANTIATHEROGENIC EFFECTS OF PROBUCOL AND OF A STRUCTURAL ANALOG OF PROBUCOL IN LOW-DENSITY-LIPOPROTEIN RECEPTOR-DEFICIENT RABBITS [J].
FRUEBIS, J ;
STEINBERG, D ;
DRESEL, HA ;
CAREW, TE .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 94 (01) :392-398
[9]
ANTIOXIDANT ACTIVITIES OF PROBUCOL AGAINST LIPID PEROXIDATIONS [J].
GOTOH, N ;
SHIMIZU, K ;
KOMURO, E ;
TSUCHIYA, J ;
NOGUCHI, N ;
NIKI, E .
BIOCHIMICA ET BIOPHYSICA ACTA, 1992, 1128 (2-3) :147-154
[10]
GOWN AM, 1986, AM J PATHOL, V125, P191